A Study of RTA 901 (BIIB143) in Participants With Diabetic Peripheral Neuropathic Pain
Clinical trial NCT05895552 · TERMINATED
Trial details
- NCT number
- NCT05895552
- Sponsor
- Reata, a wholly owned subsidiary of Biogen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-28
- Primary completion
- 2024-11-15
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.